SCHEMBL310998

SCHEMBL310998

COc1ccnc(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29787370 1.00 — —
Bromide SCHEMBL5755074 0.98 NOS3 (0.96) —
Hydrochloric Acid SCHEMBL30439931 0.98 NOS3 (0.96) —
2-Aminopyridine SCHEMBL28311779 0.89 NOS3 (0.79) —
SCHEMBL7499287 0.78 NOS3 (0.64) —
SCHEMBL31348007 0.78 NOS3 (0.64) —
SCHEMBL12555925 0.78 NOS3 (0.64) —
SCHEMBL29615484 0.78 NOS3 (0.63) —
SCHEMBL731492 0.78 NOS3 (0.63) —
SCHEMBL2644967 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118812530-A Method for preparing imidazole pyridine compound by catalyzing lignin and model compound by Pd/C bi-component system 中国科学院大连化学物理研究所 2024-10-22 — — CN claimed
WO-2021159993-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE (IRAK) /FMS-LIKE RECEPTOR TYROSINE KINASE (FLT3), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF PHARMABLOCK SCIENCES (NANJING) , INC. (CN) 2021-08-19 — — WO claimed
CN-106751439-A Carbinol-modified pnenolic aldehyde foam material of a kind of 2 aminopyridine 4 and preparation method thereof 沈阳化工大学 2017-05-31 — — CN claimed
EP-1727811-B1 NEW COMPOUNDS FOR THE INHIBITION OF ANGIOGENESIS AND USE OF THEREOF SHIRE ORPHAN THERAPIES GMBH (DE) 2014-11-12 — — EP claimed
CN-103664766-A Preparation method of 2-aminopyridine-4-methyl alcohol UNIV ZHEJIANG 2014-03-26 — — CN claimed
US-8501787-B2 Compounds for the inhibition of angiogenesis and use thereof SHIRE ORPHAN THERAPIES GMBH (DE) 2013-08-06 — — US claimed
US-8309735-B2 Heterocyclic compounds for the inhibition of integrins and use thereof SHIRE ORPHAN THERAPIES GMBH (DE) 2012-11-13 — — US claimed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 — — US claimed
US-20090203745-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2009-08-13 — — US claimed
US-20090104116-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2009-04-23 — — US claimed
WO-2007131764-A2 NEW HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2007-11-22 — — WO claimed
WO-2007088041-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2007-08-09 — — WO claimed
WO-2007079214-A2 PROKINETICIN 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-12 — — WO claimed
US-20070155712-A1 Compounds for the inhibition of angiogenesis and use thereof JERINI AG (DE) 2007-07-05 — — US claimed
WO-2005090329-A9 NEW COMPOUNDS FOR THE INHIBITION OF ANGIOGENESIS AND USE OF THEREOF JERINI AG (DE) 2007-02-01 — — WO claimed
US-7148242-B2 N-formyl hydroxylamine compounds, compositions and methods of use NOVARTIS AG (CH) 2006-12-12 — — US claimed
EP-1727811-A1 NEW COMPOUNDS FOR THE INHIBITION OF ANGIOGENESIS AND USE OF THEREOF Jerini AG (DE) 2006-12-06 — — EP claimed
CN-1856493-A Aminopyridine derivatives as inducible NO-synthase inhibitors ALTANA PHARMA AG (DE) 2006-11-01 — — CN claimed
WO-2005090329-A1 NEW COMPOUNDS FOR THE INHIBITION OF ANGIOGENESIS AND USE OF THEREOF JERINI AG (DE) 2005-09-29 — — WO claimed
US-20030045479-A1 Novel N-formyl hydroxylamine compounds, compositions and methods of use VICURON HOLDINGS LLC 2003-03-06 — — US claimed
Send feedback